[1]
Khodayi, M. et al. 2022. Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer’s disease. EXCLI Journal. 21, (May 2022), 772–785. DOI:https://doi.org/10.17179/excli2022-4764.